EDE Edenville

    AGM STATMENT
Eden Research plc, a leading UK agrochemical development company, has held its Annual General Meeting
today at which all resolutions were duly passed.
Over  the past year, Eden has focused on supporting its commercial partners Cheminova and Redestos  to
achieve product registrations in their respective territories. The processing of the dossier for 3-AEY
by  the  EU Rapporteur is on target for completion at the end of this year; no further data have  been
requested.  This  milestone would allow individual country applications to be  made  from  early  2009
onwards.
Testing  by  our  partners  continues to highlight the performance benefits  of  our  naturally  based
treatment. Field trials for label extensions in several high-value crops such as strawberries  are  in
process.
Having  granted  Cheminova extended territories under the original agreement, we are now  in  advanced
discussions with significant distributors to complete deals in other specialist markets such as Africa
and Asia.
During  the period, Eden entered into testing agreements with major European protected-crop specialist
Koppert  B.V.  and  a  leading US-based biopesticide manufacturer. These agreements  cover  short-term
testing of new development areas such as insecticidal applications and product enhancement.
Eden's  nematicide product has been subjected to extensive screening in all relevant territories  over
the past year. New application techniques supported by novel granular formulations have been developed
by  our  contract  research contractor Battelle. We plan to commence the registration  programme  next
year. Globally, markets are desperately seeking new products due to increasing regulatory restrictions
on existing soil treatments and toxic, broad-spectrum products.
In  addition,  the  company has broadened its product portfolio having identified new  leads  for  the
control  of  mites  and whitefly in high-value glasshouse crops. Eden's products  exhibited  excellent
efficacy as well as safety to many of the beneficial insects used to control pests in integrated  crop
management programmes.
Eden has rapidly developed its patented technology from concept. The safe nature of the activities has
helped  us to achieve rapid progress through the regulatory process and our first products are planned
to  be  on  the  market early next year. Much of the work is also completed on other products  in  the
company's portfolio.
I  would  like  to  thank our team for their excellent work and expect to be able to announce  further
commercial  progress in relation to the registration of our lead product 3-AEY and further  commercial
agreements over the next year.
Ken Brooks
Chairman
For further information:
Tim Griffiths, Chief Executive, Eden Research plc
T: 01993 868844
Matthew Robinson/Rose Herbert, FinnCap
T: 020 7600 1658

About Eden Research plc
Eden Research plc is a UK publicly listed company on the PLUS Market, specialising in the development
of agrochemical products and intellectual property through licensing and marketing agreements.
Eden is focused on developing products for the agricultural sector through the application of terpene
chemistry and other patented environmentally friendly technologies. Eden is currently working
alongside universities and partner companies in developing its product portfolio towards
commercialisation.
For further information, please visit www.edenresearch.com.

                                                                
Eden Research plc



                                                                

Edenville (LSE:EDE)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Edenville (LSE:EDE)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024